BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18604165)

  • 1. Confluence-induced cell cycle exit involves pre-mitotic CDK inhibition by p27(Kip1) and cyclin D1 downregulation.
    Chassot AA; Lossaint G; Turchi L; Meneguzzi G; Fisher D; Ponzio G; Dulic V
    Cell Cycle; 2008 Jul; 7(13):2038-46. PubMed ID: 18604165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
    Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
    Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
    Bhatt KV; Hu R; Spofford LS; Aplin AE
    Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation.
    Soppa U; Schumacher J; Florencio Ortiz V; Pasqualon T; Tejedor FJ; Becker W
    Cell Cycle; 2014; 13(13):2084-100. PubMed ID: 24806449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation.
    Poon RY; Toyoshima H; Hunter T
    Mol Biol Cell; 1995 Sep; 6(9):1197-213. PubMed ID: 8534916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells.
    Rivard N; Boucher MJ; Asselin C; L'Allemain G
    Am J Physiol; 1999 Oct; 277(4):C652-64. PubMed ID: 10516095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of p27(Kip1) by intracellular iron levels.
    Wang G; Miskimins R; Miskimins WK
    Biometals; 2004 Feb; 17(1):15-24. PubMed ID: 14977358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of p27(Kip1) in human intestinal cell differentiation.
    Deschênes C; Vézina A; Beaulieu JF; Rivard N
    Gastroenterology; 2001 Feb; 120(2):423-38. PubMed ID: 11159883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
    Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M
    Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A; Wang J; Wu M; Zhang X; Zhang H
    Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel target of mizoribine inhibiting mesangial cell proliferation: S phase kinase-associated protein 2.
    Liu S; Xie Y; Lv Y; Qin F; Fu B; Shi S; Yin Z; Hong Q; Zhang X; Wang J; Chang M; Chen X
    Am J Nephrol; 2010; 32(5):447-55. PubMed ID: 20924167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).
    Cheng M; Sexl V; Sherr CJ; Roussel MF
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1091-6. PubMed ID: 9448290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density growth arrest in Ras-transformed cells: low Cdk kinase activities in spite of absence of p27(Kip) Cdk-complexes.
    Groth A; Willumsen BM
    Cell Signal; 2005 Sep; 17(9):1063-73. PubMed ID: 15993748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cyclin D1 overexpression on G1 progression-related events.
    Imoto M; Doki Y; Jiang W; Han EK; Weinstein IB
    Exp Cell Res; 1997 Oct; 236(1):173-80. PubMed ID: 9344597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
    Auld CA; Fernandes KM; Morrison RF
    J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of Cdk inhibitors through both sequestration and downregulation in zearalenone-treated MCF-7 breast cancer cells.
    Ahamed S; Foster JS; Bukovsky A; Diehl JA; Wimalasena J
    Mol Carcinog; 2002 May; 34(1):45-58. PubMed ID: 12112322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK inhibitors, p21(Cip1) and p27(Kip1), participate in cell cycle exit of mammalian cardiomyocytes.
    Tane S; Ikenishi A; Okayama H; Iwamoto N; Nakayama KI; Takeuchi T
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1105-9. PubMed ID: 24380855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.
    Halfter H; Friedrich M; Resch A; Kullmann M; Stögbauer F; Ringelstein EB; Hengst L
    Cancer Res; 2006 Jul; 66(13):6530-9. PubMed ID: 16818624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
    Mann DJ; Higgins T; Jones NC; Rozengurt E
    Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.